0.6392
Schlusskurs vom Vortag:
$0.6407
Offen:
$0.63
24-Stunden-Volumen:
351.84K
Relative Volume:
0.98
Marktkapitalisierung:
$68.23M
Einnahmen:
$238.26M
Nettoeinkommen (Verlust:
$-236.56M
KGV:
-0.3926
EPS:
-1.6281
Netto-Cashflow:
$27.06M
1W Leistung:
-10.41%
1M Leistung:
-24.68%
6M Leistung:
-59.80%
1J Leistung:
-83.18%
Definitive Healthcare Corp Stock (DH) Company Profile
Firmenname
Definitive Healthcare Corp
Sektor
Branche
Telefon
508-720-4224
Adresse
492 OLD CONNECTICUT PATH, SUITE 401, FRAMINGHAM
Compare DH vs VEEV, BTSG, TEM, HQY, TXG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
DH
Definitive Healthcare Corp
|
0.6392 | 69.41M | 238.26M | -236.56M | 27.06M | -1.6281 |
|
VEEV
Veeva Systems Inc
|
243.75 | 39.23B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
61.71 | 11.81B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
52.10 | 9.85B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
104.73 | 8.82B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
TXG
10 X Genomics Inc
|
56.09 | 7.52B | 638.78M | -22.66M | 122.18M | -0.1744 |
Definitive Healthcare Corp Stock (DH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-01-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-09-17 | Eingeleitet | BTIG Research | Buy |
| 2024-07-31 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-05-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-17 | Herabstufung | Needham | Buy → Hold |
| 2024-01-05 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-07-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2023-04-19 | Eingeleitet | William Blair | Outperform |
| 2022-12-09 | Eingeleitet | BofA Securities | Neutral |
| 2022-07-06 | Eingeleitet | Needham | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2022-02-24 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-12-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-10-11 | Eingeleitet | Barclays | Equal Weight |
| 2021-10-11 | Eingeleitet | Canaccord Genuity | Hold |
| 2021-10-11 | Eingeleitet | Credit Suisse | Neutral |
| 2021-10-11 | Eingeleitet | Deutsche Bank | Hold |
| 2021-10-11 | Eingeleitet | Goldman | Neutral |
| 2021-10-11 | Eingeleitet | JP Morgan | Neutral |
| 2021-10-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-10-11 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-10-11 | Eingeleitet | Stifel | Buy |
Alle ansehen
Definitive Healthcare Corp Aktie (DH) Neueste Nachrichten
Definitive Healthcare posts a stellar 41.44% RO... - pluang.com
Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N.V. (ATAI) - The Globe and Mail
Deutsche Bank Adjusts Definitive Healthcare Price Target to $1 From $3, Maintains Hold Rating - marketscreener.com
Definitive Healthcare Corp. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:DH) 2026-08-11 - Seeking Alpha
Definitive Healthcare Corp. Stock 12‑Month Price Target Cut to $1.7, Implies 143% Upside - TradingView
Morgan Stanley Adjusts Definitive Healthcare PT to $1.50 From $2.50, Maintains Equalweight Rating - marketscreener.com
Definitive Healthcare Corp (DH) (Q2 2026) Earnings Call Highlights: AI Platform Launch and ... - Yahoo Finance UK
Definitive Healthcare earnings beat by $0.01, revenue fell short of estimates - Investing.com Canada
Definitive Healthcare revenue falls 9% in Q2, cash flow holds - scanx.trade
Earnings call transcript: Definitive Healthcare tops Q2 2026 EPS forecast By Investing.com - Investing.com Nigeria
Definitive Healthcare Q2 2026 slides: profit beats amid revenue decline - Investing.com
Earnings call transcript: Definitive Healthcare tops Q2 2026 EPS forecast - Investing.com
Definitive Healthcare Q2 Earnings Call Highlights - MarketBeat
Definitive Healthcare Corp. (DH) Q2 Earnings Surpass Estimates - Yahoo Finance
Definitive Healthcare Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Definitive Healthcare (NASDAQ:DH) Releases Q3 2026 Earnings Guidance - MarketBeat
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Form 8K Definitive Healthcare Corp For: 10 August By Investing.com - Investing.com South Africa
Definitive Healthcare Q3 Results: Sales and EPS miss estimates - scanx.trade
Definitive Healthcare Raises FY26 Adj EPS Guidance to $0.18-$0.20 - scanx.trade
Definitive Healthcare (NASDAQ:DH) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Definitive Healthcare Corp. Q2 2026: Revenue $55.2M, EPS $(0.05) — 10-Q Summary - TradingView
Definitive Healthcare (DH) books $197M goodwill hit and faces Nasdaq bid-price risk - Stock Titan
Definitive Healthcare (Nasdaq: DH) Q2 2026 revenue hits $55.2M amid large write-down - Stock Titan
Definitive Healthcare Reports Financial Results for Second Quarter 2026 - Yahoo Finance
Definitive Healthcare Q2 2026 slides: profit beats amid revenue decline By Investing.com - Investing.com Nigeria
Definitive Healthcare Corp expected to post earnings of 4 cents a shareEarnings Preview - TradingView
Definitive Healthcare Set to Report Q2 With GF Value Pointing to 520% Upside - finance.biggo.com
Earnings To Watch: Definitive Healthcare Corp (DH) Q2 2026 -- GF Value Sees 520% Upside - Yahoo Finance
Definitive Healthcare Corp. (DH) Stock Analysis: Exploring The 221% Potential Upside - DirectorsTalk Interviews
Definitive Healthcare launches early access AI platform By Investing.com - Investing.com South Africa
Definitive Healthcare launches early access AI platform - Investing.com
Definitive Healthcare Launches Early Adopter Program for New AI-Powered Healthcare Intelligence Platform - Yahoo Finance
Definitive Healthcare Corp (DH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Definitive Healthcare Corp. (DH) chair has 12,166 shares withheld for tax - Stock Titan
Definitive Healthcare (DH) CFO has 1,881 shares withheld to cover RSU taxes - Stock Titan
Definitive Healthcare to report Q2 2026 earnings on August 10 with a live webcast and call. - Pluang
Definitive Healthcare Announces Timing of Its Second Quarter 2026 Financial Results Conference Call and Webcast - The Manila Times
Definitive Healthcare (DH) Expected to Release Quarterly Earnings on Monday - MarketBeat
Definitive Healthcare Q2 Results: Earnings call set for Aug 10 - scanx.trade
Analysts Estimate Definitive Healthcare Corp. (DH) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Definitive Healthcare LLC Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Definitive Healthcare Corp (DH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Definitive Healthcare Corp (DH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Definitive Healthcare Corp (DH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Definitive Healthcare's New AI and Data Leader Gets 1.06M RSUs - Stock Titan
Definitive Healthcare Corp. (NASDAQ:DH) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat
Definitive Healthcare Corp (DH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Definitive Healthcare Corp. (DH) Q1 2026 Earnings: EPS Surges 79% Above Estimates Amid Strong Operational EfficiencyQuarterly Earnings - dars.gov.et
Definitive Healthcare Corp (DH) Cash Flow - TradingKey
Finanzdaten der Definitive Healthcare Corp-Aktie (DH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):